Trial intelligence / Profile preview

Genexol-PM vs Genexol in Recurrent or Metastatic Breast Cancer

NCT00876486Phase 3Completed

Sponsor
Samyang Biopharmaceuticals Corporation
Start
Dec 2008
Primary completion
Feb 2013
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of paclitaxel polymeric micelle in breast cancer, sponsored by Samyang Biopharmaceuticals Corporation. Started Dec 2008; status: completed.

02

Drugs

paclitaxel polymeric micelle
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00876486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00876486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call